Effectiveness and Safety of Switching Rapid-Acting Insulins to Insulin Glulisine in Patients with Diabetes: The Observational IGLU-S Study

INTRODUCTION: The IGLU-S study assessed the effectiveness of insulin glulisine after switching from human insulin/other rapid-acting insulin analogues in patients with type 1 diabetes (T1DM) and type 2 diabetes (T2DM) in a real-world setting in Germany. METHODS: Open-label, prospective, multicentre,...

Descripción completa

Detalles Bibliográficos
Autores principales: Seufert, Jochen, Pfohl, Martin, Borck, Anja, Bramlage, Peter, Siegmund, Thorsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947079/
https://www.ncbi.nlm.nih.gov/pubmed/33544356
http://dx.doi.org/10.1007/s13300-021-00999-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947079/
https://www.ncbi.nlm.nih.gov/pubmed/33544356
http://dx.doi.org/10.1007/s13300-021-00999-y

Ejemplares similares